Guide to EU R&D funding opportunities

14 September 2008

Earlier this month, the European Commission launched a "Practical Guide to EU funding opportunities for Research and Innovation," aimed at helping all stakeholders to find their way into the different existing European Union funding.

It points out that, central to the realization of the research goals of the Lisbon Agenda (Marketletters passim) is the need to promote the knowledge economy, in particular through research, technological development and innovation. EU support for RTDI is provided mainly through the 7th Research Framework Program, the Competitiveness and Innovation Framework Program and the Structural & Cohesion Funds. If their impact is to be maximized, it is essential that these sources of funding are used in a coherent way, it stresses.

When operating individually, these three funding sources already act as effective tools in support of RTDI. However, the Commission notes, their value can be further enhanced by combining them.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight